CAPRICOR THERAPEUTICS, INC. (CAPR)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$105.4M
Cash & Equivalents
$29.3M
Quarterly Burn Rate
11 mo
Est. Cash Runway
$1,246M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2026-08-22 Pdufa —

FDA-Related SEC Filings

DateTypeDescriptionLink
2026-06-26 8-K CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869) - 8-K EDGAR

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for CAPR.

SEC EDGAR Filings

All SEC filings for CAPRICOR THERAPEUTICS, INC. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.